Background: Several non-traditional factors are associated with increased risk of atherosclerosis among patients with acute coronary syndrome (ACS). Objective: This study aimed to detect predictors for the premature atherosclerosis in patients less or equal than 45 years old in men and less than 55 years old in female and severity of premature atherosclerosis in acute coronary syndrome. Patients and methods: This cross-sectional study included 105 patients with acute coronary syndrome attended for angiography at Cardiology Department, Zagazig University Hospitals. Patients were divided equally into: Group (I) included young patient having traditional risk factors only with acute coronary syndrome, group (II) included young patients having nontraditional risk factors only such as Apo A-I and Apo B and increased lymphocyte to monocyte ratio with acute coronary syndrome and group (III) that included young patient having both traditional and nontraditional risk factors such as ApoA-I, m Apo B and increased lymphocyte to monocyte ratio with acute coronary syndrome. In all groups severity of atherosclerosis was assessed by Gensini score system. Results: About 2/3 of acute coronary syndrome with traditional risk factors group (62.9%) had severe atherosclerosis, with high statistically significant difference between the 3 groups. Hypertension was the only significant traditional factor in relation to severity of atherosclerosis. Also, obese patients had severe atherosclerosis 5 times more than nonobese. Odds of having severe atherosclerosis was 2.66 times more among males than females. Conclusion: A variety of significant non-traditional risk factors place patients at higher risk for ACS. We recommend taking these factors in consideration as regards assessment of occurrence and severity of premature atherosclerosis and ACS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.